BlinkAid Overview
BlinkAid develops a wearable application for the prevention and alleviation of Dry Eye and Computer Vision Syndromes’ burden. Blink Aid's solution makes use of glasses frame as a platform. The company's patent is a protected technology, embedded onto the users’ personal glasses, monitor blinks’ rate and quality to compensate for improper blinking using highly specific and personally tailored neurostimulation. In practice BlinkAid is to be the first to make use of the glasses for other medical aid other than vision correction and the first to address Dry Eye Symptoms via the natural mechanism of blinking.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
עין יבשה: הסטארט-אפ הישראלי שהחליט לפתור את הבעיה בלי אף טיפה
BlinkAid, an Israeli startup, is developing an innovative solution to address dry eye syndrome, a condition exacerbated by prolonged screen time and high concentration activities. The company, led by CTO Raz Karl and CMO Dr. Yiftach Yassur, has created a prototype of smart glasses that use AI to monitor and stimulate blinking patterns. This non-pharmacological approach aims to prevent the chronic progression of dry eye syndrome by ensuring proper tear distribution. BlinkAid plans to launch the product within two years and will soon begin clinical trials at Beilinson Hospital. The startups solution could potentially benefit millions globally who suffer from this condition.
CustomersExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
2
Employees: 1-10
Web & Social Links
Locations
Jerusalem, Israel
Photos & Videos
No files yet
